Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Similar documents
Singapore Exchange Limited 1Q FY2009 Financial Results

1Q2017 法人說明會 Jun. 9, 2017

May 6, 2008 First Quarter 2008 Results

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group. A Member of the Hong Leong Group ANNUAL REPORT 2008

CENTRALE. Monetary. compared. domestic. million.

Telekom Austria Group Results for the 1st Quarter May 27, 2003

For personal use only

BancAnalysts Association of Boston Conference Presentation. November 3, 2017

Group financial results for the first quarter 2008

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

FINANCIAL RESULTS 1H 2016 Growth in key volumes and core revenues

Summary of Results for the First Half of FY2015/3

FINANCIAL RESULTS 1H 2015 Core revenues supporting 2015 plan delivery

FY2016 1H Results. Cookpad Inc.

Korean Airlines Q Results

Welcome to LG Electronics

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016

Q Investor Kit JANUARY-MARCH 2014

FIRSTQUARTER2018 RESULTSPRESENTATION

1Q16 FINANCIAL RESULTS

Woongjin Coway. 1Q 12 IR Presentation

For personal use only

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Genomic Health. Kim Popovits, Chairman, CEO and President

DELICA D:5 ACTIVE GEAR 0

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

FY2007 Consolidated Financial Overview

Singapore Press Holdings. 1Q FY12 Financial Results 10 January 2012

TELECONFERENCE Q August 2015

ARUBA RECENT ECONOMIC DEVELOPMENTS AND OUTLOOK. Presented by Jane R. Semeleer President Centrale Bank van Aruba May 30, 2011

Cochlear Limited Results for the half year ended 31 December 2007

Corporate Presentation October New growth cycle and value innovation

Q Investor Kit January December 2014

1Q 2014 Earnings Release

Supplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016

1Q 2015 Results A Positive Start to 2015

Investor Presentation

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Q Investor Kit JANUARY-JUNE 2014

Endesa 1Q 2017 Results 09/05/2017

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011

Interim Report 1 January September 2017

For personal use only

Slide 1. Investor presentation. London 5 February 2019

Summary Statement of Financial Position (consolidated)

Interim report Second quarter 2017 and subsequent events (Unaudited)

Forward Looking Information

Portfolio Strategy Group

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Portfolio Strategy Group

Group 1Q FY13 financial highlights

Small-Cap Research. VolitionRx Ltd (VNRX-NYSE) VNRX: More Positive Data in Colon/Lung Cancers. Anticipating Initial Launch This Year OUTLOOK

RAI: Strong key-brands performance delivers 2Q13 profit growth; Company reaffirms full-year EPS guidance

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

PRESENTATION ON 2017 THIRD QUARTERLY RESULTS

Fisher & Paykel Healthcare

Q Investor Kit January December 2015

Small-Cap Research. Diffusion Pharmaceuticals Inc. (DFFN-NASDAQ) DFFN: FDA Gives Final Guidance for Phase 3 Protocol for TSC in Inoperable GBM OUTLOOK

China Insulin Industry Report, Jan. 2011

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

MICROCAP LEADERSHIP SUMMIT

EUROZ INVESTOR CONFERENCE

THIRD QUARTER REPORT 2011 (UNAUDITED)

Corporate Presentation 1Q18. New growth cycle and value innovation

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

ELICA 2012 Q3 RESULTS. November 14,

Third-quarter results 2013

Results Briefing. 15 ~ 17 May 2007

For personal use only

HONG LEONG TOP YIELD ACCOUNT TERMS & CONDITIONS ( T&Cs )

6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store

TELECONFERENCE Q November 2015

ONO PHARMACEUTICAL CO., LTD.

Enel Américas 1Q 2018 results

For personal use only

Q2 INVESTOR KIT JANUARY-JUNE 2011

ONO PHARMACEUTICAL CO., LTD.

Q Investor Kit JANUARY-MARCH 2013

22nd Century Group, Inc. (XXII - $ Buy) Q1 Far Ahead of Expectations

M e d i a s e t G r o u p

2010 First Quarter Results Presentation. 11 th May 2010

Third Quarter Results to September 30, 2009

Presentation of. Burgdorf, 1 st November 2012

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

Altria Group Inc. Ticker: MO

QUALITAS MEDICAL GROUP LIMITED. CORPORATE PRESENTATION January 2010

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

artnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016

BVI Limited Partnership Hedge Funds: Calling Japan

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Zacks Small-Cap Research

METVIX PDT ON THE MARKET IN GERMANY AND UK

Transcription:

Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed to parties outside the presentation. DBS Bank accepts no liability whatsoever with respect to the use of this document or its contents.

First quarter net profit at $ 412 million ($ million) 1Q 1Q YoY % 4Q QoQ % 2005 2004 change 2004 change Net profit excluding 412 592 (30%) 426 (3%) goodwill amortization Net profit on GAAP 412 482 (15%) 316 30% basis* * FRS 103 accounting change for goodwill amortization not retroactively applied to 2004 reported results 2

Nine consecutive quarters of loan growth; net interest income highest in ten quarters Customer loans* $ 71 billion 22% $ 13 billion Net interest income $ 664 million * Exclude DBS Thai Danu Bank 3

Sustained growth in customer franchise across the region Net profit Consumer, SME $ 233 million 18% Consumer $ 150 million 25% SME $ 83 million 6% Consumer, SME combined accounted for 57% of DBS total net profit for the quarter 4

Strong asset quality, balance sheet supports DBS growth Asset quality one of the best among Asian banks NPL rate of 2.4% Provision coverage of 90% Strong balance sheet Moody s Aa2 credit rating among highest of banks competing in Asia-Pacific Tier 1 ratio: 10.9% Overall CAR: 15.3% 5

Delivering sustainable and progressively increasing dividends Instituted quarterly dividend programme First Quarter 2005 dividend set at 11 cents per share 6

Well-positioned to achieve further growth, deliver higher returns to shareholders More balanced and diversified business mix Strengthened customer franchise Up-to-date risk management practices, technology and operations platform Continue to extend business model to new geographies, grow our share in existing markets 7

Operating profits improve 16% on quarter from revenue growth and lower expenses (S$m) 1Q 2005 1Q 2004 % change 4Q 2004 % change Net interest income 664 634 5 636 4 Non-interest income 408 636 (36) 391 4 Operating income 1,072 1,270 (16) 1,027 4 Staff costs 265 257 3 259 2 Other operating expenses 244 257 (5) 282 (13) Operating expenses 509 514 (1) 541 (6) Operating profit 563 756 (26) 486 16 Provisions/(write-backs) 62 50 24 (31) nm Net profit before goodwill 412 592 (30) 426 (3) Goodwill amortisation - 110 (100) 110 (100) Net profit 412 482 (15) 316 30 8

Key ratios generally unchanged on quarter (%) 1Q 2005 4Q 2004 1Q 2004 Net interest margin 1.76 1.75 1.79 Non-interest income/total income 38 38 50 Cost/income 47 53 40 ROE 9.9 10.5 15.8 Loans/deposits 61 62 58 Loan + non-trading debt securities/ deposits 81 82 78 NPL ratio 2.4 2.5 4.6 9

Net interest income highest in ten quarters, margins steady (S$m) Net interest margin (%) 2,645 2,375 2,566 1.99 1.78 1.79 1.79 1.79 1.83 1.75 1.76 634 651 645 636 664 2002 2003 2004 1Q 2Q 3Q 4Q 1Q 2004 2005 10

Loans expand 14% on year to record (S$m) DTDB loans 2% 71,060 2,915 2% 2,915 4% 3,275 3% 4% 69,664 61,420 62,429 65,053 67,221 Dec 2003 Mar 2004 Jun 2004 Sep 2004 Dec 2004 Mar 2005 11

Fee income from annuity businesses remains steady (S$m) 1800 1500 1200 900 600 300 0 1,422 36 35 814 60 a 548 a 1,840 44 901 87 852 1,883 1,031 105 747 b 48 42 b 50 636 281 13 342 58 39 41 38 38 b 409 447 391 408 244 252 254 253 44 31 17 121 164 120 13 142 2002 2003 2004 1Q 2Q 3Q 4Q 1Q b 2004 Fee income Dividend & rental Other income Non-interest income / total income (%) 2005 (a) Excluding one-time gains of $96m (b) Excluding one-time gains of $497m 12

Wealth management sales improve, revenues rise 16% on quarter (S$m) 9,006 9,242 Structured deposits Bancassurance Unit trusts 7,227 5,908 429 2,766 2,545 1,732 2,093 2,065 27 1,526 1,838 200 1,157 2,905 964 1,685 327 41 41 1,578 1,006 34 374 691 834 868 2003 2004 1Q 2Q 3Q 4Q 1Q Sales (all products) 2004 2005 S pore 4,162 3,874 1,244 918 1,028 684 963 HK 4,844 5,368 1,522 1,175 1,517 1,154 1,102 Fees (unit trusts and bancassurance only) S pore + HK 90 132 34 24 42 32 37 13

Revenues rebound on quarter, customer businesses resilient (S$m) 1Q 2005 1Q 2004 Change 4Q 2004 Change Consumer Banking 414 384 30 401 13 Enterprise Banking 182 182 0 186 (4) Corporate and Investment Banking 174 176 (2) 162 12 Global Financial Markets 170 409 (239) 147 23 Central Treasury Unit 46 108 (62) 85 (39) Central Operations 86 11 75 46 40 Total 1,072 1,270 (198) 1,027 45 14

Operating costs kept under control (S$m) 1,868 46 a 45 1,869 44 2,049 46 41 b 40 46 32 b 46 Cost/Income (%) 53 47 514 492 502 541 509 2002 2003 2004 1Q 2Q 3Q 4Q 1Q 2004 2005 Annualised cost / average assets (%) 1.22 1.17 1.22 1.22 1.14 1.20 1.27 1.14 Headcount c 12,035 12,144 11,454 12,173 10,838 11,083 11,454 11,649 Staff costs (S$m) 911 876 995 257 232 247 259 265 (a) Excluding one-time gains of $96m (b) Excluding one-time gains of $497m (c) At period end 15

Hong Kong s net profit 27% lower on year (S$m) 1Q 1Q % 4Q % 2005 2004 change 2004 change Net interest income 200 219 (9) 205 (2) Non-interest income 99 139 (29) 124 (20) Operating income 299 358 (16) 329 (9) Operating expenses 151 142 6 158 (4) Op profit before provisions 148 216 (31) 171 (13) Provisions 7 25 (72) 23 (70) Net profit 121 165 (27) 129 (6) Exchange rate at HK$1 to S$0.21160 for all periods. Based on Singapore GAAP 16

Key Hong Kong ratios continue to support group (%) 1Q 2005 4Q 2004 1Q 2004 Net interest margin 1.92 1.96 2.31 Non-interest income/total income 33 38 39 Cost/income 51 48 40 ROA 1.06 1.11 1.56 Loans/deposits 75 75 73 17

Regional revenues continue to grow at faster pace Amount (S$m) 1Q 2004 1Q 2005 YoY change (%) Revenues Region and rest of world a Hong Kong Singapore Total 60 365 808 1,233 85 298 689 1,072 42 (18) (15) (13) Net profit b Region and rest of world a 32 13 (59) Hong Kong 168 124 (26) Singapore 376 275 (27) Total 576 412 (40) (a) Excluding DTDB in all periods (b) Excluding goodwill amortisation 18

NPL rate edges down to 2.4% (S$m) Substandard Doubtful Loss 7500 6.1 5.2 2.5 4.6 3.0 2.6 2.5 NPL rate (%) 2.4 5000 4,224 3,780 3,359 2500 74% 73% 1,919 75% 2,182 1,934 1,919 1,928 0 6% 20% 5% 22% 71% 9% 20% 6% 19% 72% 9% 19% 70% 9% 21% 71% 9% 20% 72% 9% 19% 2002 2003 2004 Mar Jun Sep Dec Mar 2004 2005 19

Non-performing loans stable as additions offset recoveries and write-offs (S$m) 1Q 2005 4Q 2004 1Q 2004 NPLs at start of period 1,919 1,934 3,780 New NPLs 185 325 150 Net recoveries of existing NPLs (135) (261) (396) Write-offs (41) (79) (175) NPLs at end of period 1,928 1,919 3,359 20

Specific provision charges remain low (S$m) 1Q 2005 4Q 2004 1Q 2004 Add charges for New NPLs 51 74 52 Existing NPLs 33 41 61 85 115 113 Subtract charges for Upgrading 2 2 5 Settlements 34 63 73 Recoveries 6 13 6 42 79 84 Total SP charges 43 36 29 21

Provision coverage improves to 90% (S$m) 5000 4000 GP SP 3000 2000 1000 0 2,500 2,387 2,271 989 1,064 1,701 1,819 1,752 1,701 1,736 1,072 1,015 1,025 1,037 1,015 1,036 1,511 1,323 1,199 686 794 715 686 700 2002 2003 2004 Mar Jun Sep Dec Mar Coverage ratios (%) 2004 2005 SP+GP / Unsec NPAs 121 124 186 132 156 183 186 202 SP+GP / NPAs 59 63 89 68 83 91 89 90 22

Tier-1 CAR trimmed as RWA expands in 1Q (%) 28 24 Tier-2 CAR Tier-1 CAR 20 16 12 15.5 15.1 5.2 4.6 15.8 4.5 14.5 4.1 15.6 15.4 15.8 15.3 4.0 3.6 4.5 4.4 8 4 10.3 11.3 10.4 11.6 11.8 10.5 11.3 10.9 0 2002 2003 2004 Mar Jun Sep Dec Mar 2004 2005 (S$bn) Tier-1 capital 8.4 9.6 11.8 10.2 11.2 11.5 11.8 11.8 RWA 81.2 92.1 104.0 97.8 96.6 97.5 104.0 108.8 2004 capital ratios based on MAS framework. Earlier periods based on BIS guidelines 23

Quarterly dividend rate of 11 cents (Cents) Final Interim Quarterly 50 40 30 20 30 30 16 16 40 22 10 0 14 14 18 11 2002 2003 2004 1Q 2005 24

Growth in core businesses offsets weaker non-interest income April 29, 2005 DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts This presentation is available at www.dbs.com/investor Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed to parties outside the presentation. DBS Bank accepts no liability whatsoever with respect to the use of this document or its contents.